head-and-neck-cancer | Media Room

Press Release Aug 23, 2021

Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant

Press Release Aug 19, 2021

Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition

Press Release Jun 3, 2021

Privo Technologies, Inc. to Present Phase II Data for PRV111 in Head and Neck Squamous Cell Carcinoma at the Upcoming 2021 ASCO Annual Meeting

Press Release Jun 30, 2020

Privo Technologies Announces the Appointment of Dr. James Mackay to Its Board of Directors

Privo Technologies (Privo), a Leader in the Field of Novel, Nanotechnology-Based Localized Oncology Treatments, is Pleased to Announce the Appointment of Dr. James Mackay to Its Board of Directors.

Press Release Sep 12, 2018

Gladstone Scientists Map Interactions Between Head and Neck Cancer and HPV Virus

Connecting the dots between human papillomavirus and smoking-related cancers

Press Release Aug 16, 2016

Fine Needle Aspiration (FNA Specialist) - Celina M. Nadelman, MD Answers Questions in New Video